| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 76.253 | 47.404 | 70.539 | 91.197 | 61.748 | 53.911 | 15.201 |
| Total Income - EUR | - | - | 0 | 84.209 | 81.392 | 87.675 | 91.197 | 64.415 | 108.951 | 128.348 |
| Total Expenses - EUR | - | - | 1.572 | 58.001 | 76.797 | 60.539 | 81.338 | 63.558 | 104.747 | 124.278 |
| Gross Profit/Loss - EUR | - | - | -1.572 | 26.207 | 4.595 | 27.137 | 9.859 | 857 | 4.204 | 4.070 |
| Net Profit/Loss - EUR | - | - | -1.577 | 25.443 | 4.132 | 26.544 | 9.056 | 338 | 3.638 | 3.568 |
| Employees | - | - | 0 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Holendomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.841 | 45.581 | 38.501 | 32.403 | 44.995 | 48.584 | 300.099 | 313.011 |
| Current Assets | - | - | 19.633 | 59.546 | 4.681 | 6.199 | 6.005 | 17.424 | 127.632 | 2.583 |
| Inventories | - | - | 19.618 | 15 | 110 | 170 | 121 | 1.965 | 2.094 | 0 |
| Receivables | - | - | 1 | 49.353 | 2.714 | 3.272 | 4.797 | 6.494 | 27.352 | 5.315 |
| Cash | - | - | 13 | 10.178 | 1.857 | 2.757 | 1.087 | 8.965 | 98.186 | -2.732 |
| Shareholders Funds | - | - | -1.533 | 23.938 | 21.632 | 29.535 | 30.919 | 27.178 | 30.733 | 34.130 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 23.007 | 46.555 | 21.550 | 9.067 | 20.082 | 65.923 | 364.841 | 314.634 |
| Income in Advance | - | - | 0 | 34.648 | 0 | 0 | 0 | 0 | 77.062 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Holendomed S.r.l.